• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Public Health

Poor patient recruitment hinders randomized controlled trials

byJeffrey CohenandBrittany Hasty, MD
March 13, 2014
in Public Health
Reading Time: 3 mins read
PCR associated with limited diagnostic utility in viral URI
Share on FacebookShare on Twitter

Image: PD 

1. Poor participant recruitment was found to be the most common cause of randomized controlled trial (RCT) discontinuation.

2. Factors associated with not publishing results of RCTs include small target sample size, single center design, industry sponsorship, RCT discontinuation, and studies of healthy volunteers as opposed to patients.

Evidence Rating Level:  2 (Good) 

Study Rundown: Despite the fact that randomized controlled trials (RCTs) require a great deal of resources, a proportion of them are never completed.  There are several potential reasons for this including inability to recruit an adequate number of participants, clear benefit from the intervention, and clear harm from the intervention.  This study retrospectively reviewed RCT protocols from six institutions in Germany, Switzerland, and Canada approved between 2000-2003 to determine the reasons for the discontinuations that occurred.  Of the 1017 included RCT protocols, 253 trials were discontinued (24.9%, 95%).  The most common cause of discontinuation was poor recruitment (101 of 1017 trials).  When the study period ended, 567 (55.8%) of the RCTs were published in peer-reviewed journals.  Overall, uncompleted RCTs were less likely to be published than completed RCTs (55.1% vs. 33.6%, p<0.001).  A strength of this study is the thorough analysis done by experts of each RCT protocol.  A weakness of the study is the fact that the trials come from a relatively small number of sites.

Click to read the study in JAMA

RELATED REPORTS

FDA-cleared AI devices rarely have patient outcome data

Food and Drug Administration reviews model for predicting drug related liver injury

Metformin remains a leading candidate for pharmacologic longevity intervention

Relevant Reading: Learning from failure–rationale and design for a study about discontinuation of randomized trials (DISCO study)

In-Depth [retrospective cohort]: This study retrospectively reviewed 1017 RCT protocols approved between 2000 and 2003 by six research ethics committees in Germany, Switzerland, and Canada. In the cohort, 253 trials were discontinued (24.9%, 95% CI 22.3%-27.6%), most commonly because of inadequate participant recruitment (101/1017, 9.9%, 95% CI 8.2%-12.0%). The factors associated with discontinuation due to poor recruitment were small planned sample size (p=0.04) and investigator as opposed to industry sponsorship (p<0.001).  Administrative reasons for discontinuation were identified in 3.8% of trials.  Discontinuation due to early intervention benefit occurred in 0.9% of trials and discontinuation due to harm of the intervention occurred in 2.4% of trials. In all, 567 (55.8%, 95% CI 52.6%-58.8%) of the RCTs were published as full articles in journals. The factors associated with non-publication were small sample size target (p<0.001), single center RCTs (p=0.001), investigator sponsorship (p=0.002), discontinued RCTs (p<0.001), and RCTs with patients as opposed to healthy volunteers (p<0.001).

More from this author: Risk-reduction counseling with HIV testing may not decrease rates of sexually transmitted infections, Autoantibodies may precede symptom onset in Sjögren’s Syndrome, Varenicline and buproprion more effective than varenicline alone for tobacco abstinence, Peer based health education program linked to reduced waist circumference, No overall change in the prevalence of obesity in the United States between 2003 and 2012

 ©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: Clinical trials
Previous Post

Idelalisib may be effective in treating relapsed indolent lymphoma [DELTA Study]

Next Post

Mutations in PKA catalytic subunit associated with Cushing’s syndrome

RelatedReports

Public Health

FDA-cleared AI devices rarely have patient outcome data

September 10, 2026
American College of Physicians releases principles to guide patient partnership in health care
All Specialties

Food and Drug Administration reviews model for predicting drug related liver injury

September 4, 2026
Metformin treats Fragile X syndrome symptoms in mice [PreClinical]
Chronic Disease

Metformin remains a leading candidate for pharmacologic longevity intervention

May 19, 2026
Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease
Oncology

Spiritual health may be high among cancer patients in drug clinical trials

November 7, 2023
Next Post
Mutations in PKA catalytic subunit associated with Cushing’s syndrome

Mutations in PKA catalytic subunit associated with Cushing’s syndrome

Rituximab noninferior to conventional therapy in ANCA-associated vasculitis: RAVE Trial

Idelalisib plus rituximab improves progression-free survival in relapsed CLL

Gestational weight loss may improve outcomes for obese women

DNA methylation associated with higher body-mass index

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.